中国带状疱疹诊疗专家共识（2022版）

doi:10.35541/cjd.20220608

Abstract

Abstract: 【Abstract】 Herpes zoster is an infectious skin disease caused by the reactivation of varicella-zoster virus, and characterized by skin lesions and neuropathic pain. Based on the consensus of Chinese experts on herpes zoster （2018 version）, this consensus comprehensively evaluates and analyzes the existing problems in the diagnosis and treatment of herpes zoster in China, especially in the selection of therapeutic drugs, treatment for special populations and of special types of herpes zoster, management of herpes zoster complications such as postherpetic neuralgia, and herpes zoster vaccination, aimming to better guide the standardized diagnosis and treatment of herpes zoster in clinic practice.

Key words: Herpes zoster, Neuralgia, postherpetic, Preventive health services, Diagnosis, Therapeutics, Consensus

Consensus Workgroup on Herpes Zoster, China Dermatologist Association, National Clinical Research Center for Skin and Immune Diseases. Chinese consensus on the diagnosis and management of herpes zoster （2022）[J]. Chinese Journal of Dermatology, 2022, 55(12): 1033-1040.doi:10.35541/cjd.20220608

References ［50］

［1］	中国医师协会皮肤科医师分会带状疱疹专家共识工作组. 带状疱疹中国专家共识［J］. 中华皮肤科杂志, 2018,51（6）:403⁃408. doi: 10.3760/cma.j.issn.0412⁃4030.2018.06.001.
［2］	Bao L, Wei G, Gan H, et al. Immunogenicity of varicella zoster virus glycoprotein E DNA vaccine［J］. Exp Ther Med, 2016,11（5）:1788⁃1794. doi: 10.3892/etm.2016.3086.
［3］	Sauerbrei A. Diagnosis, antiviral therapy, and prophylaxis of varicella⁃zoster virus infections［J］. Eur J Clin Microbiol Infect Dis, 2016,35（5）:723⁃734. doi: 10.1007/s10096⁃016⁃2605⁃0.
［4］	Alles S, Smith PA. Etiology and pharmacology of neuropathic pain［J］. Pharmacol Rev, 2018,70（2）:315⁃347. doi: 10.1124/pr. 117.014399.
［5］	Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective［J/OL］. BMJ Open, 2014,4（6）:e004833. doi: 10.1136/bmjopen⁃2014⁃004833.
［6］	Chen LK, Arai H, Chen LY, et al. Looking back to move forward: a twenty⁃year audit of herpes zoster in Asia⁃Pacific［J］. BMC Infect Dis, 2017,17（1）:213. doi: 10.1186/s12879⁃017⁃2198⁃y.
［7］	Kawai K, Yawn BP, Wollan P, et al. Increasing incidence of herpes zoster over a 60⁃year period from a population⁃based study［J］. Clin Infect Dis, 2016,63（2）:221⁃226. doi: 10.1093/cid/ciw296.
［8］	Tseng HF, Bruxvoort K, Ackerson B, et al. The epidemiology of herpes zoster in immunocompetent, unvaccinated adults ≥ 50 years old: incidence, complications, hospitalization, mortality, and recurrence［J］. J Infect Dis, 2020,222（5）:798⁃806. doi: 10. 1093/infdis/jiz652.
［9］	van Oorschot D, Vroling H, Bunge E, et al. A systematic literature review of herpes zoster incidence worldwide［J］. Hum Vaccin Immunother, 2021,17（6）:1714⁃1732. doi: 10.1080/21645 515.2020.1847582.
［10］	邓慧杰, 刘芳勋. 我国带状疱疹流行病学特征及疫苗免疫规划研究进展［J］. 中国继续医学教育, 2021,13（19）:135⁃138. doi: 10.3969/j.issn.1674⁃9308.2021.19.039.
［11］	Yenikomshian MA, Guignard AP, Haguinet F, et al. The epidemiology of herpes zoster and its complications in Medicare cancer patients［J］. BMC Infect Dis, 2015,15:106. doi: 10.1186/s12879⁃015⁃0810⁃6.
［12］	Grabar S, Tattevin P, Selinger⁃Leneman H, et al. Incidence of herpes zoster in HIV⁃infected adults in the combined antiretroviral therapy era: results from the FHDH⁃ANRS CO4 cohort［J］. Clin Infect Dis, 2015,60（8）:1269⁃1277. doi: 10.1093/cid/ciu1161.
［13］	Olivera PA, Lasa JS, Bonovas S, et al. Safety of Janus kinase inhibitors in patients with inflammatory bowel diseases or other immune⁃mediated diseases: a systematic review and meta⁃analysis［J］. Gastroenterology, 2020,158（6）:1554⁃1573.e12. doi: 10.1053/j.gastro.2020.01.001.
［14］	Diez⁃Domingo J, Parikh R, Bhavsar AB, et al. Can COVID⁃19 increase the risk of herpes zoster? a narrative review［J］. Dermatol Ther （Heidelb）, 2021,11（4）:1119⁃1126. doi: 10.1007/s13555⁃021⁃00549⁃1.
［15］	Johnson RW, Rice AS. Clinical practice. Postherpetic neuralgia［J］. N Engl J Med, 2014,371（16）:1526⁃1533. doi: 10.1056/NEJMcp1403062.
［16］	Mittal A, Srivastava A, Balai M, et al. A study of postherpetic pruritus［J］. Indian Dermatol Online J, 2016,7（4）:343⁃344. doi: 10.4103/2229⁃5178.185479.
［17］	Kim YJ, Lee CN, Lee MS, et al. Recurrence rate of herpes zoster and its risk factors: a population⁃based cohort study［J］. J Korean Med Sci, 2019,34（2）:e1. doi: 10.3346/jkms.2019.34.e1.
［18］	Stratman E. Visceral zoster as the presenting feature of disseminated herpes zoster［J］. J Am Acad Dermatol, 2002,46（5）:771⁃774. doi: 10.1067/mjd.2002.119091.
［19］	Gross GE, Eisert L, Doerr HW, et al. S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia［J］. J Dtsch Dermatol Ges, 2020,18（1）:55⁃78. doi: 10.1111/ddg.14013.
［20］	曾永芬, 金毅. 带状疱疹后神经痛发病危险因素研究进展［J］. 中国疼痛医学杂志, 2020,26（8）:603⁃607. doi: 10.3969/j.issn.1006⁃9852.2020.08.009.
［21］	Chen N, Li Q, Yang J, et al. Antiviral treatment for preventing postherpetic neuralgia［J］. Cochrane Database Syst Rev, 2014,（2）:CD006866. doi: 10.1002/14651858.CD006866.pub3.
［22］	Lamoureux C, Flatrès C, Vallet S, et al. Aseptic meningitis caused by the Varicella⁃zoster virus after primary infection in an immunocompetent child: a case report［J］. Ann Biol Clin （Paris）, 2018,76（2）:234⁃236. doi: 10.1684/abc.2018.1331.
［23］	杨慧兰. 带状疱疹中国专家共识解读［J］. 中华皮肤科杂志, 2018,51（9）:699⁃701. doi: 10.3760/cma.j.issn.0412⁃4030.2018. 09.021.
［24］	Cunningham AL, Breuer J, Dwyer DE, et al. The prevention and management of herpes zoster［J］. Med J Aust, 2008,188（3）:171⁃176. doi: 10.5694/j.1326⁃5377.2008.tb01566.x.
［25］	Werner RN, Nikkels AF, Marinović B, et al. European consensus⁃based （S2k） Guideline on the Management of Herpes Zoster ⁃ guided by the European Dermatology Forum （EDF） in cooperation with the European Academy of Dermatology and Venereology （EADV）, Part 2: Treatment［J］. J Eur Acad Dermatol Venereol, 2017,31（1）:20⁃29. doi: 10.1111/jdv.13957.
［26］	Jeon YH. Herpes zoster and postherpetic neuralgia: practical consideration for prevention and treatment［J］. Korean J Pain, 2015,28（3）:177⁃184. doi: 10.3344/kjp.2015.28.3.177.
［27］	Degreef H. Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients［J］. Int J Antimicrob Agents, 1994,4（4）:241⁃246. doi: 10.1016/0924⁃8579（94）90024⁃8.
［28］	Ono F, Yasumoto S, Furumura M, et al. Comparison between famciclovir and valacyclovir for acute pain in adult Japanese immunocompetent patients with herpes zoster［J］. J Dermatol, 2012,39（11）:902⁃908. doi: 10.1111/j.1346⁃8138.2012.01584.x.
［29］	Lin WR, Lin HH, Lee SS, et al. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster［J］. J Microbiol Immunol Infect, 2001,34（2）:138⁃142.
［30］	Wassilew SW, Wutzler P. Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia［J］. Antiviral Res, 2003,59（1）:57⁃60. doi: 10.1016/s0166⁃3542（03）00064⁃0.
［31］	Watanabe D, Mizukami A, Holl K, et al. The potential public health impact of herpes zoster vaccination of people aged ≥ 50 years in Japan: results of a Markov model analysis［J］. Dermatol Ther （Heidelb）, 2018,8（2）:269⁃284. doi: 10.1007/s13555⁃018⁃0236⁃3.
［32］	Lapolla W, Digiorgio C, Haitz K, et al. Incidence of postherpetic neuralgia after combination treatment with gabapentin and valacyclovir in patients with acute herpes zoster: open⁃label study［J］. Arch Dermatol, 2011,147（8）:901⁃907. doi: 10.1001/archdermatol.2011.81.
［33］	Migita T. Can early administration of pregabalin reduce the incidence of postherpetic neuralgia?［J］. Clin Exp Dermatol, 2014,39（6）:755⁃756. doi: 10.1111/ced.12386.
［34］	Liang L, Li X, Zhang G, et al. Pregabalin in the treatment of herpetic neuralgia: results of a multicenter Chinese study［J］. Pain Med, 2015,16（1）:160⁃167. doi: 10.1111/pme.12564.
［35］	带状疱疹后神经痛诊疗共识编写专家组. 带状疱疹后神经痛诊疗中国专家共识［J］. 中国疼痛医学杂志, 2016,22（3）:161⁃167. doi: 10.3969/j.issn.1006⁃9852.2016.03.001.
［36］	Chen N, Yang M, He L, et al. Corticosteroids for preventing postherpetic neuralgia［J］. Cochrane Database Syst Rev, 2010,（12）:CD005582. doi: 10.1002/14651858.CD005582.pub3.
［37］	Koshy E, Mengting L, Kumar H, et al. Epidemiology, treatment and prevention of herpes zoster: a comprehensive review［J］. Indian J Dermatol Venereol Leprol, 2018,84（3）:251⁃262. doi: 10.4103/ijdvl.IJDVL_1021_16.
［38］	Kimberlin DW, Jacobs RF, Weller S, et al. Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age［J］. Clin Infect Dis, 2010,50（2）:221⁃228. doi: 10.1086/649212.
［39］	Rao S, Abzug MJ, Carosone⁃Link P, et al. Intravenous acyclovir and renal dysfunction in children: a matched case control study［J］. J Pediatr, 2015,166（6）:1462⁃1468.e1⁃4. doi: 10.1016/j.jpeds.2015.01.023.
［40］	De Paschale M, Clerici P. Microbiology laboratory and the management of mother⁃child varicella⁃zoster virus infection［J］. World J Virol, 2016,5（3）:97⁃124. doi: 10.5501/wjv.v5.i3.97.
［41］	Lilie HM, Wassilew S. The role of antivirals in the management of neuropathic pain in the older patient with herpes zoster［J］. Drugs Aging, 2003,20（8）:561⁃570. doi: 10.2165/00002512⁃200320080⁃00002.
［42］	刘巧. 中西医结合皮肤病治疗学［M］. 北京: 人民军医出版社, 2014.
［43］	Pei W, Zeng J, Lu L, et al. Is acupuncture an effective postherpetic neuralgia treatment? A systematic review and meta⁃analysis［J］. J Pain Res, 2019,12:2155⁃2165. doi: 10.2147/JPR.S199950.
［44］	任玲, 王时巧, 王媚. 如意金黄散联合针灸治疗急性带状疱疹的临床观察［J］. 中国中医急症, 2020,29（11）:2014⁃2016. doi: 10.3969/j.issn.1004⁃745X.2020.11.037.
［45］	邓诗清, 李茜, 陈晓峰, 等. 电针治疗老年带状疱疹的临床疗效研究［J］. 实用中西医结合临床, 2019,19（6）:149⁃150,173. doi: 10.13638/j.issn.1671⁃4040.2019.06.078.
［46］	李长华, 甄宗礼, 李泳. 物理治疗联合药物治疗带状疱疹疗效分析［J］. 当代医学, 2019,25（31）:119⁃121. doi: 10.3969/j.issn. 1009⁃4393.2019.31.047.
［47］	Chen YT, Wang HH, Wang TJ, et al. Early application of low⁃level laser may reduce the incidence of postherpetic neuralgia （PHN）［J］. J Am Acad Dermatol, 2016,75（3）:572⁃577. doi: 10.1016/j.jaad.2016.03.050.
［48］	中国医疗保健国际交流促进会皮肤科分会, 中华医学会皮肤性病学分会老年性皮肤病研究中心. 带状疱疹疫苗预防接种专家共识［J］. 中华医学杂志, 2022,102（8）:538⁃543. doi: 10. 3760/cma.j.cn112137⁃20210828⁃01958.
［49］	Cunningham AL, Lal H, Kovac M, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older［J］. N Engl J Med, 2016,375 （11）:1019⁃1032. doi: 10.1056/NEJMoa 1603800.
［50］	Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults［J］. N Engl J Med, 2015,372（22）:2087⁃2096. doi: 10.1056/NEJMoa 1501184.

[1]	Chen Qitao, Li Yuqian, Shao Guanghui, Zhu Jing, Zhu Qilin, Li Zhongming, Du Xufeng, Fan Weixin. Erosive pustular dermatosis of the scalp [J]. Chinese Journal of Dermatology, 2023, 0(2): 20210803-e20210803.
[2]	Yang Ji, Xu Xinzhi, Li Ming. Early diagnosis of dermatomyositis and early recognition of visceral injury [J]. Chinese Journal of Dermatology, 2023, 56(2): 161-164.
[3]	Chinese Society of Dermatology, Chinese Association of Rehabilitation Dermatology, Combination of Traditional and Western Medicine Dermatology, The Dermatology Branch of Chinese Medical Education Association. Expert consensus on diagnosis and treatment of senile herpes zoster [J]. Chinese Journal of Dermatology, 2023, 56(2): 97-104.
[4]	Du Fangzhi, Zhang Xu, Wang Qianqiu. Monkeypox: clinical manifestations, diagnosis, treatment and follow-up [J]. Chinese Journal of Dermatology, 2023, 56(1): 76-81.
[5]	Rosacea Research Center, Chinese Society of Dermatology, Rosacea Professional Committee, China Dermatologist Association. Expert consensus on intradermal injections with botulinum toxin A for the treatment of flushing and persistent erythema caused by rosacea [J]. Chinese Journal of Dermatology, 2023, 56(1): 16-21.
[6]	Li Wei, Li Zheng . Atopic dermatitis with typical and atypical manifestations [J]. Chinese Journal of Dermatology, 2023, 56(1): 1-4.
[7]	Immunology Group, Chinese Society of Dermatology. Consensus on the whole-process management of atopic dermatitis [J]. Chinese Journal of Dermatology, 2023, 56(1): 5-15.
[8]	Lei Jiehao, Hong Weisong, Lin Fuquan, Hu Wenting, Xu Ai′e. In vitro culture of melanocytes from segmental vitiligo-like nevus depigmentosus lesions and its clinical significance [J]. Chinese Journal of Dermatology, 2022, 55(9): 798-802.
[9]	Lyu Sha, Wang Shuang, Wu Hanfei, Zhang Mingrui, Hu Xin, Li Fuqiu. Research progress in sporotrichosis [J]. Chinese Journal of Dermatology, 2022, 55(7): 629-632.
[10]	Luo Shuaihantian, Long Hai, Lu Qianjin, . Research advances in systemic lupus erythematosus in 2021 [J]. Chinese Journal of Dermatology, 2022, 55(4): 369-372.
[11]	Environmental and Occupational Skin Disease Research Group, Committee on Dermatology, Chinese Association of Integrative Medicine, Group on Children, Chinese Society of Dermatology. Expert consensus on clinical application of wet-wrap therapy for atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(4): 289-294.
[12]	Environmental and Occupational Skin Disease Research Group, Committee on Dermatology, Chinese Association of Integrative Medicine, Group on Children, Chinese Society of Dermatology, Committee on Dermatology, Chinese Association of Geriatric Research. Expert consensus on rational application of topical agents and patient education for atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(4): 281-288.
[13]	Li Suo, Xiang Ruiyu, Li Zhiliang, Jing Ke, Wang Yuan, Zhang Hanmei, Feng Suying. Evaluation of the value of indirect immunofluorescence on salt-split skin in the diagnosis of bullous pemphigoid [J]. Chinese Journal of Dermatology, 2022, 55(3): 235-237.
[14]	Writing committee expert group on “diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement （2022） [J]. Chinese Journal of Dermatology, 2022, 55(3): 187-195.
[15]	Lyu Ling, Lyu Xiaoyan. Dermatomyositis with malignancy: an update [J]. Chinese Journal of Dermatology, 2022, 55(3): 276-279.

Chinese consensus on the diagnosis and management of herpes zoster （2022）

PDF

Knowledge

Abstract

Cite this article

share this article

References ［50］

Related Articles 15

Metrics

Comments

Recommended 10